A novel YAP1/SLC35B4 regulatory axis contributes to proliferation and progression of gastric carcinoma
Jun Liu(Jinan University), Jipeng Li(Shanghai Jiao Tong University), Ke Wang(Xijing Hospital), Long Zhang(Zhejiang Cancer Hospital), Xiang Zhang(The Affiliated Yongchuan Hospital of Chongqing Medical University), Yunlong Li(Xijing Hospital), Shun Zhang(East China Normal University), Rui Zhang(Air Force Medical University), Angang Yang(Henan Medical University), Yuan Guo(Central South University), Yanping Yu(Xi'an Medical University), Xinhui Zhao(Air Force Medical University), Yongzhi Lv(Xi'an Medical University)
Cited by 29
Related Papers
SARS-CoV-2 Omicron variant: recent progress and future perspectives
|Signal Transduction and Targeted Therapy|2022|631
RNA m6A methylation orchestrates cancer growth and metastasis via macrophage reprogramming
|Nature Communications|2021|414
Targeted Delivery of CRISPR/Cas9‐Mediated Cancer Gene Therapy via Liposome‐Templated Hydrogel Nanoparticles
|Advanced Functional Materials|2017|297
Follistatin-like 1 (Fstl1) is a bone morphogenetic protein (BMP) 4 signaling antagonist in controlling mouse lung development
|Proceedings of the National Academy of Sciences|2011|219
Engineering a precise adenine base editor with minimal bystander editing
|Nature Chemical Biology|2022|183